Genscript Biotech Corporation

Holdings MV

1.90B

Last Updated

2025-07-01

Total Holdings

Tracker Performance

Genscript Biotech Corporation

S&P 500

Total Return

-24.56%

Annualized Return

-26.46%

1 Day Change

-3.89%

Sharpe Ratio

-0.39

Trade Updates

2025-07-01

Ticker

Name

07/01

Buy

0.00%

Fill Price --

100.00%

Current Holdings

Genscript Biotech Corporation maintains a prominent position in the Medical Biology sector (100.00%), which serves as the cornerstone of the portfolio. The remaining capital is allocated across other industries and other industries, balancing sector-specific growth potential with risk management.

Medical Biology

100.00%

Symbol

P&L %

Position Size

Ticker

Name

-24.56%

100.00%

Disclaimer

This simulated portfolio Tracker is based on holdings disclosed in institutional 13F filings. We select the top 20 holdings and construct a portfolio weighted by their relative proportions. Holdings beyond the top 20 are excluded, as their impact on the portfolio is minimal. Focusing on the top 20 enhances practicality and reflects the institution's stock-picking ability. The portfolio is periodically rebalanced to align with updated 13F filings. Note that 13F disclosures typically have a 45-day delay (e.g., Q2 2025 data is disclosed by mid-August). Users should consider this lag when tracking the portfolio, though institutional holdings are generally long-term, emphasizing strategic rationale behind changes. This portfolio is for illustrative purposes only and does not constitute investment advice. All investment decisions are the user's responsibility. Investing involves risks, including potential loss of principal. Past performance is not indicative of future results.

Frequently Asked Questions

How many stocks does Genscript Biotech Corporation currently hold?

As of the latest update on 2025-07-01, the Genscript Biotech Corporation portfolio consists of 1 individual holdings. The portfolio is actively managed to optimize strategy performance.

How has Genscript Biotech Corporation's portfolio performed recently?

Over the recent period, Genscript Biotech Corporation has demonstrated significant growth. The portfolio currently shows a Total Return of -24.56%, with an Annualized Return of -26.46%, outperforming standard market benchmarks.

What is the total portfolio value (AUM) of Genscript Biotech Corporation?

The current market value of Genscript Biotech Corporation's disclosed holdings is approximately $1.90B. This figure reflects the value of assets tracked based on their latest filing.